open menu open menu
CONTACT US

THE
STATISTICS

Over 150 million men worldwide suffer from sexual performance problems. Although the risk of erectile dysfunction (ED) increases with age, it is not an inevitable side effect of getting older.

ED PREVALENCE (by age group)
Singapore household survey; N = 729; IIEF-5 questionnaire Tan et al, Singapore Med J. 2003 Jan; 44(1):20-6. Panach-Navarrete et al, Actas Urol Esp. 2017 May;41(4):258-266

COMMON CAUSES OF ERECTILE DYSFUNCTION

Various risk factors can contribute to erectile dysfunction, including:

  • Medical condition

  • Injuries

  • Smoking

  • Medications

  • Obesity

  • Psychological conditions

  • Certain medical treatments

  • Drug and alcohol use

...Current treatment of ED focuses on temporary symptomatic relief rather than on addressing the cause. Shockwave therapy could play an important role as the only currently available option that focuses on disease modification and restoration of erectile function

Source: Kalyvianakis D, Memmos E, Mykoniatis I, Kapoteli P, Memmos D, Hatzichristou D. “The Journal of Sexual Medicine”. Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Randomized Clinical Trial Comparing 2 Treatment Protocols and the Impact of Repeating Treatment. March 2018

Pills vs ESWT
  1. Giuliano F, Assaly-Kaddoum R, Laurin M, Bernabé J, Behr-Roussel D."981 - Low intensity shockwave therapy (Li-ESWT) delivered by Aries® improves erectile function and decreases cavernosal fibrosis of spontaneously hypertensive rats (SHR)."Eur Urol Suppl. 2018 Mar 1;17(2):e1384.
  2. Kalyvianakis D, Memmos E, Mykoniatis I, Kapoteli P, Memmos D, Hatzichristou D."Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Randomized Clinical Trial Comparing 2 Treatment Protocols and the Impact of Rep eating Treatment." J Sex Med. 2018 Mar;15(3):334–45.
  3. Zewin T, El-Assmy A, Harraz A, Elsherbini A, Musa Z, Bayoumi A, et al."1115 Low-intensity extracorporeal shock wave therapy for severe erectile dysfunction in poor responders to phosphodiesterase type-5 inhibitors: A short-term prospective study." Eur Urol Suppl. 2016 Mar 1;15(3):e1115.
  4. Mild discomfort may be experienced in some cases, depending on the individual patient.

This website contains general information about medical conditions and treatments. The information is not advice and should not be treated as such. If you have any specific questions about any medical matter you should consult your doctor or other professional healthcare provider. Please see the medical disclaimer page for full details. This site is protected by copyright and trademark laws under U.S. and International law. Terms and Conditions. All rights reserved. ©2021 Dornier MedTech.

All rights reserved. ©2021 Dornier MedTech.
DMT530-022019-REV A EN